BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21684094)

  • 21. Derrick Edward Award Lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model.
    Cassell GH
    Rev Infect Dis; 1982; 4 Suppl():S18-34. PubMed ID: 6981830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vpma phase variation is important for survival and persistence of Mycoplasma agalactiae in the immunocompetent host.
    Chopra-Dewasthaly R; Spergser J; Zimmermann M; Citti C; Jechlinger W; Rosengarten R
    PLoS Pathog; 2017 Sep; 13(9):e1006656. PubMed ID: 28957426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AIDS-associated mycoplasmas.
    Blanchard A; Montagnier L
    Annu Rev Microbiol; 1994; 48():687-712. PubMed ID: 7826023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Vpma phase variation in Mycoplasma agalactiae pathogenesis.
    Chopra-Dewasthaly R; Baumgartner M; Gamper E; Innerebner C; Zimmermann M; Schilcher F; Tichy A; Winter P; Jechlinger W; Rosengarten R; Spergser J
    FEMS Immunol Med Microbiol; 2012 Dec; 66(3):307-22. PubMed ID: 22809092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Being pathogenic, plastic, and sexual while living with a nearly minimal bacterial genome.
    Sirand-Pugnet P; Lartigue C; Marenda M; Jacob D; Barré A; Barbe V; Schenowitz C; Mangenot S; Couloux A; Segurens B; de Daruvar A; Blanchard A; Citti C
    PLoS Genet; 2007 May; 3(5):e75. PubMed ID: 17511520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics inference of genes involved in host adaptation of Mycoplasma gallinarum.
    Wan XF; Branton SL; Collier SD; Evans JD; Leigh SA; Pharr GT
    Vet Microbiol; 2010 Sep; 145(1-2):177-84. PubMed ID: 20378283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beware of Mycoplasma Anti-immunoglobulin Strategies.
    Arfi Y; Lartigue C; Sirand-Pugnet P; Blanchard A
    mBio; 2021 Dec; 12(6):e0197421. PubMed ID: 34781733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal transfers in mycoplasmas: when minimal genomes go mobile.
    Dordet-Frisoni E; Sagné E; Baranowski E; Breton M; Nouvel LX; Blanchard A; Marenda MS; Tardy F; Sirand-Pugnet P; Citti C
    mBio; 2014 Nov; 5(6):e01958. PubMed ID: 25425234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenicity of avian mycoplasmas.
    Stipkovits L
    Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):171-83. PubMed ID: 44612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xer1-independent mechanisms of Vpma phase variation in Mycoplasma agalactiae are triggered by Vpma-specific antibodies.
    Czurda S; Hegde SM; Rosengarten R; Chopra-Dewasthaly R
    Int J Med Microbiol; 2017 Dec; 307(8):443-451. PubMed ID: 29122515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycoplasmas: sophisticated, reemerging, and burdened by their notoriety.
    Baseman JB; Tully JG
    Emerg Infect Dis; 1997; 3(1):21-32. PubMed ID: 9126441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative conjugative elements are widespread in field isolates of Mycoplasma species pathogenic for ruminants.
    Tardy F; Mick V; Dordet-Frisoni E; Marenda MS; Sirand-Pugnet P; Blanchard A; Citti C
    Appl Environ Microbiol; 2015 Mar; 81(5):1634-43. PubMed ID: 25527550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attachment by mycoplasmas and its role in disease.
    Collier AM
    Rev Infect Dis; 1983; 5 Suppl 4():S685-91. PubMed ID: 6415783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycoplasmas - Identifying hosts for a stealth pathogen.
    Clark J
    Vet J; 2005 Nov; 170(3):273-4. PubMed ID: 16266841
    [No Abstract]   [Full Text] [Related]  

  • 35. Unveiling the stealthy tactics: mycoplasma's immune evasion strategies.
    Wang J; Liang K; Chen L; Su X; Liao D; Yu J; He J
    Front Cell Infect Microbiol; 2023; 13():1247182. PubMed ID: 37719671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenicity of strains of the IJKNQR group of avian mycoplasmas for turkey embryos and poults.
    Rhoades KR
    Avian Dis; 1981; 25(1):104-11. PubMed ID: 7271648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adherence of pathogenic mycoplasmas to host cells.
    Razin S
    Biosci Rep; 1999 Oct; 19(5):367-72. PubMed ID: 10763804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Mycoplasma gallisepticum virulence factor lipoprotein MslA is a novel polynucleotide binding protein.
    Masukagami Y; Tivendale KA; Mardani K; Ben-Barak I; Markham PF; Browning GF
    Infect Immun; 2013 Sep; 81(9):3220-6. PubMed ID: 23798535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative genomics of four Mycoplasma species of the human urogenital tract: Analysis of their core genomes and virulence genes.
    Roachford OSE; Nelson KE; Mohapatra BR
    Int J Med Microbiol; 2017 Dec; 307(8):508-520. PubMed ID: 28927691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early stages in the interaction between Mycoplasma gallisepticum and the chick trachea, as related to pathogenicity and immunogenicity.
    Levisohn S
    Isr J Med Sci; 1984 Oct; 20(10):982-4. PubMed ID: 6511325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.